|
| 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Basic information |
Product Name: | 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- | Synonyms: | 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- | CAS: | 43059-50-3 | MF: | C20H28O2 | MW: | 300.44 | EINECS: | | Product Categories: | | Mol File: | 43059-50-3.mol | |
| 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Chemical Properties |
| 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Usage And Synthesis |
Uses | 11,12-Dihydro-11-hydroxyretinoic Acid δ-Lactone is an intermediate used in the synthesis of 4-Keto 13-cis-Retinoic acid-d3 (K204972), which is labeled metabolite of Retinoic Acid in neuroblastoma. |
| 2H-Pyran-2-one, 5,6-dihydro-4-methyl-6-[(1E,3E)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-butadien-1-yl]- Preparation Products And Raw materials |
|